Generics

Pharmaceutical firms launch Stelara biosimilars

Stelara biosimilars are used to treat certain inflammatory conditions.
FDA accepts Alvotech, Teva's BLA for proposed Eylea biosimilar

Eylea is a biologic used to treat eye disorders, including diseases which can lead to vision loss or blindness.
Amneal launches generic Asacol HD, receives FDA nod for generic Revlimid

Mesalamine is indicated for the treatment of moderately active ulcerative colitis in adults; lenalidomide is indicated for the treatment of several blood cancers.
FDA gives Sanofi-Aventis green light for Novolog biosimilar

Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA.
Aurora Pharmaceutical releases generic for Equine pain relief

EquiCoxib is a non-steroidal anti-inflammatory drug used for pain and inflammation associated with osteoarthritis.
AAM: IRA hampers generic, biosimilar drug competition

AAM said the law sets up a process under which a drug would have price controls applied before a generic or biosimilar even had the chance to come to market.
Impax, Dr. Reddy’s settle dispute over generic Rytary

Impax Laboratories and Dr. Reddy’s have settled their patent infringement dispute over Rytary, a medication used to treat Parkinson’s disease.
What do consumers really think about generics?

A Tebra survey found that 84% of Americans believe generic medications are just as effective as their brand-name counterparts.

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar